etylmetylhydroksypyrydyna succinate succinate succinate | Mexifine ampoules 50 mg / ml 2 ml, 10 pcs.

Latin name

Mexifin

Release form

Solution for i / v and / m administration colorless or slightly yellowish, transparent.

Packaging

2 ml - ampoules (5) - contour plastic packaging (2) - packs of cardboard.

Indications

anxiety states with neurotic and neurosis-like states

vegetative-vascular dystonia

discirculatory encephalopathy

mild cognitive impairment of atherosclerotic genesis of srdloprino acute syndrome

disorders acute intoxication with antipsychotic drugs

acute suppurative inflammation flax processes in the abdomen (including acute necrotizing pancreatitis, peritonitis (as part of complex therapy))

acute myocardial infarction from the first day (parenteral)

ischemic heart disease

complex therapy for ischemic stroke (oral) - as part of complex therapy.

Contraindications

hypersensitivity

acute liver and / or renal failure

pregnancy

lactation

childhood.

Caution: if there is a history of allergic diseases (for parenteral administration).

Use during pregnancy and lactation

Contraindicated in pregnancy, during lactation.

Composition

1 ml 1 amp.

2 ethyl-6-methyl-3-hydroxypyridine succinate 50 mg 100 mg

Excipients: water d / i.

Side effects

Nausea, dry mouth, diarrhea, drowsiness, allergic reactions.

When administered parenterally (especially intravenously): dryness, metallic taste in the mouth, sensations of heat spreading throughout the body, unpleasant odor, sore throat and discomfort in the chest, a feeling of lack of air (usually associated with an excessively high rate of administration and are of a short duration) with prolonged use - nausea, flatulence of sleep disturbance (drowsiness or falling asleep).

Drug Interaction

Enhances the effects of benzodiazepine anxiolytics, antiepileptic (carbamazepine), antiparkinsonian (levodopa) drugs, nitrates.

Reduces toxic effects of ethanol.

Overdose

Symptoms: sleep disorders (insomnia, in some cases drowsiness) with / in the introduction - a slight and short-term (up to 1.5-2 h) increase in blood pressure.

Treatment: usually not required. The symptoms disappear on their own within a day. In severe cases, with insomnia - nitrazepam 10 mg, oxazepam 10 mg or diazepam 5 mg. In case of excessive elevation of blood pressure, antihypertensive drugs are controlled by blood pressure.

Storage conditions

In a dry, dark place at a temperature of no higher than 25 РC.

Keep out of the reach of children.

The Expiration of

is 3 years.

Do not use after the expiry date stated on the package.

Deystvuyuschee substances

Эtylmetylhydroksypyrydyna succinate

Possible Product Names

Mexiphine 50mg / ml 2ml No. 10

Mexiphine ampoules 50mg / ml 2ml, 10 pcs.

Mexifine solution for i / v i.v. administration 50mg / ml 2ml N10 amp

Federal State Unitary Enterprise Pharmaceutical Protection Russia,